MMSI merit.com: Company Value to Revenue

Official company branding of Merit Medical (MMSI)

Steady demand from global hospitals for consumables supports Merit Medical Systems (MMSI). Technological progress in minimally invasive catheters and FDA patents provide the company with a competitive moat. The EV/Revenue multiple on the GURU.Markets terminal chart reflects valuation dynamics, where 3331.60 represents the latest level, helping investors objectively assess asset value relative to sales.

merit.com (MMSI): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

MMSI (Merit Medical Corp): analytical breakdowns and indicator data

- current quotes and average value forecast:
Initial company analysis:Merit Medical Systems
Manufactured products of Merit Medical Systems Inc

This metric assesses the market value of the business inclusive of net debt, determining the efficiency of revenue generation relative to the total cost of acquiring the asset. This EV/Sales ratio allows for a correlation between the investment in the innovative R&D potential of Merit Medical Systems (MMSI) and actual sales volumes, reflecting the market premium for the quality of engineering solutions and the stability of the company's operating cash flows.

Competitor analysis for Merit Medical Systems

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|NVST - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio ICU Medical Corp ICUI|XRAY: EV/Sales Multiple|LMAT (LeMaitre Vascular, Inc.) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue ATRC|STAA (STAAR Surgical) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ChromaDex (NAGE)|Company Value to Revenue ZimVie Inc. ZIMV|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple